April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Liver X Receptor signaling pathways and age-related macular degeneration
Author Affiliations & Notes
  • Goldis Malek
    Ophthalmology and Pathology, Duke University, Durham, NC
  • Mayur Choudhary
    Ophthalmology, Duke University, Durham, NC
  • Edwin Meade
    Ophthalmology, Duke University, Durham, NC
  • Erik Nelson
    Pharmacology and Cancer Biology, Duke University, Durham, NC
  • Donald McDonnell
    Pharmacology and Cancer Biology, Duke University, Durham, NC
  • Footnotes
    Commercial Relationships Goldis Malek, None; Mayur Choudhary, None; Edwin Meade, None; Erik Nelson, None; Donald McDonnell, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3458. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Goldis Malek, Mayur Choudhary, Edwin Meade, Erik Nelson, Donald McDonnell; Liver X Receptor signaling pathways and age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3458.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Age-related macular degeneration (AMD) is the leading cause of vision loss in the elderly. The early dry sub-type is characterized by accumulation of cholesterol-rich deposits below the retinal pigment epithelium (sub-RPE). Recent studies have identified several genes associated with AMD risk, in the high-density lipoprotein cholesterol pathway, including the ATP binding cassette transporter 1 (ABCA1). Liver X receptors (LXRs) are nuclear receptors that act as cholesterol sensors regulating not only lipid-metabolism and genes associated with reverse cholesterol transport including ABCA1, but also inflammation. Given the importance of lipid metabolism and inflammation in the pathogenesis of early dry AMD, we investigated the impact of LXR activation in RPE and choroidal endothelial cells, cells affected in AMD, and examined the eye phenotype of aged LXR double knockout mice.

Methods: LXR expression and activity were determined in ARPE19 and RF/6A endothelial cells treated with endogenous lipids, synthetic agonists and antagonists of the receptor using qPCR, western blot and luciferase assays. Expression of inflammatory and lipid-processing genes were measured in cells following treatment with agonists and antagonists and following knockdown of the receptor. In vivo examination of LXR knockout mice included evaluating the morphology of retina/RPE/choroid and histochemical staining for lipids.

Results: We found that the LXRs are present and the signaling pathway can be activated using synthetic agonists in human RPE and endothelial cells. Inflammatory genes including MCP-1, TLR3 and 4 and lipid processing genes ABCA1 and SREBP are regulated by LXR. In vivo, the absence of LXR in 9 month old mice resulted in accumulation of lipid-rich, oil red o positive, sub-RPE deposits underlying approximately 80% the length of the RPE, along with lipid droplets within the RPE and Bruch’s membrane.

Conclusions: These findings support the physiological importance of LXR in lipid metabolism and inflammation in the RPE and choroidal endothelial cells and indicate that the LXR signaling pathway may be a potential therapeutic target against cholesterol-rich deposit formation.

Keywords: 412 age-related macular degeneration • 583 lipids • 701 retinal pigment epithelium  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.